from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3237c/-

LFCtreatmentdescriptionclass of inhibitor

0.660

Amikacinug/mL Amikacintranslation

0.589

Cap5-10ug/mL Capreomycintranslation

0.740

Rox10-50 ug/mL Roxithromycintranslation

0.173

SM2-5 ug/mL Streptomycintranslation

2.626

Tet5-10 ug/mL Tetracyclinetranslation

0.137

Rif0.2-5ug/mL Rifampicintranscription

-0.460

Rifp0.1-0.5ug/mL Rifapentinetranscription

5.235

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.073

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.164

CPZ10-50 ug/mL Chlorpromazinerespiration

1.357

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.104

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.990

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.746

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.193

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.428

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.282

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.288

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.362

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.591

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.672

KCN5-20 ug/mL Potassium cyaniderespiration

-1.341

NaN30.2-2 mM Sodium aziderespiration

0.256

Nigericin50 uM Nigericinrespiration

0.473

TRC10-150 ug/mL Triclosanrespiration

1.494

TRZ10-25 ug/mL Thioridazinerespiration

-0.199

Valinomycin0.5-10 uM Valinomycinrespiration

-0.879

ZnSO42 mM ZnSO4respiration

-0.023

menadione6-10 ug/mL Menadionerespiration

-0.033

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.443

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.007

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.195

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.030

NRP_1Non-replicating persistence stage 1dosRassociated

-0.253

Amp0.2mg/mL AmpicillincellWall

-0.473

Cephalexin20-100 ug/mL CephalexincellWall

-0.904

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.773

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.340

EMB10-20 ug/mL EthambutolcellWall

-0.106

Eta12-40 ug/mL EthionamidecellWall

-0.193

INH0.2-0.4 ug/mL IsoniazidcellWall

0.119

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.277

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.192

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.687

BZA0.12 mg/mL BenzamidearomaticAmides

-0.456

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.380

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.038

H2O24 mM hydrogen peroxideDNAdamaging

-0.055

Levo10 ug/mL LevofloxacinDNAdamaging

-0.523

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.085

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.117

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.537

UVUV-irradiationDNAdamaging

1.380

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.171

Antimycin12.5-50 ug/mL Antimycin A?

-0.140

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.397

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.263

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.135

PA8240.2-2 ug/mL PA-824?

0.490

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.382

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.270

Verapamil50 uM Verapamil?

-0.054

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.830

methoxatin10-20 ug/mL Methoxatin?